SCHEMBL30541682

SCHEMBL30541682

COc1ccc(-c2nc3c(C)nc(-c4ccc(N5CCC6(CC5)CN(CC(C)C)C6)cc4)cc3n2C)cc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 6/20 0.38
▸ TLR7 Q9NYK1 5/20 0.38
▸ TLR8 Q9NR97 5/20 0.38
▸ MAP4K1 Q92918 1/20 0.37
▸ MAPT P10636 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ SMPD3 Q9NY59 1/20 0.35
▸ USP2 O75604 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ DRD2 P14416 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25366449 1.00 TLR9 (0.38) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL25365431 0.93 TLR9 (0.37) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL30541634 0.93 TLR9 (0.37) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL30541587 0.90 TLR9 (0.42) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL25365416 0.90 TLR9 (0.42) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL25363993 0.89 MAP4K1 (0.40) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL30541621 0.89 MAP4K1 (0.40) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL25364535 0.89 TLR9 (0.39) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL30541602 0.89 TLR9 (0.39) TLR9TLR7TLR8MAP4K1MAPT
SCHEMBL25365853 0.88 MAP4K1 (0.36) TLR9TLR7TLR8MAP4K1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479407-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2024-12-25 — — EP disclosed
WO-2023159153-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 BRISTOL-MYERS SQUIBB COMPANY (US) 2023-08-24 — — WO disclosed
Send feedback